Bridgeway Capital Management’s Sight Sciences SGHT Stock Holding History

Bridgeway Capital Management’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$248K	Sell	65,733 -35,000	-35%	-$189K	0.01%	983
2025 Q4	$799K	Buy	100,733 +4,300	+4%	+$27.5K	0.02%	742
2025 Q3	$332K	Hold	96,433	–	–	0.01%	895
2025 Q2	$398K	Hold	96,433	–	–	0.01%	810
2025 Q1	$231K	Buy	96,433 +5,900	+7%	+$16.6K	0.01%	893
2024 Q4	$330K	Hold	90,533	–	–	0.01%	902
2024 Q3	$570K	Sell	90,533 -55,867	-38%	-$376K	0.01%	831
2024 Q2	$976K	Hold	146,400	–	–	0.02%	690
2024 Q1	$773K	Buy	146,400 +25,000	+21%	+$118K	0.02%	813
2023 Q4	$626K	Buy	+121,400	New	+$375K	0.01%	886

Other funds holding SGHT

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bridgeway Capital Management's SGHT Position: Q1 2026 in Review

Bridgeway Capital Management reduced its Sight Sciences (SGHT) stake by 35% in Q1 2026, selling an estimated $189K and leaving 65,733 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #983.

Bridgeway Capital Management first reported a position in SGHT in Q4 2023 and has held it in 10 quarters since. The position peaked at $976K in Q2 2024. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

Bridgeway Capital Management held 65,733 shares of Sight Sciences worth $248K as of Q1 2026.
Bridgeway Capital Management sold 35,000 Sight Sciences shares in Q1 2026, an estimated $189K.
Sight Sciences made up 0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #983 holding.
Bridgeway Capital Management first reported a position in Sight Sciences in Q4 2023 and has held it in 10 quarters since.
Bridgeway Capital Management's Sight Sciences position peaked at $976K in Q2 2024.
114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.